Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Merck
AstraZeneca
Medtronic
Moodys

Last Updated: September 26, 2022

Litigation Details for CyDex Pharmaceuticals, Inc. v. Alembic Global Holding SA (D. Del. 2019)


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Small Molecule Drugs cited in CyDex Pharmaceuticals, Inc. v. Alembic Global Holding SA

Details for CyDex Pharmaceuticals, Inc. v. Alembic Global Holding SA (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-05-23 1 Complaint and lawfully issued United States Patent No. 9,200,088 (“the ’088 patent”), entitled “Sulfoalkyl Ether … COUNT I FOR INFRINGEMENT OF U.S. PATENT NO. 9,200,088 26. CyDex realleges and incorporates…and interest in the ’088 patent and the ’582 patent (collectively, “the patents-in-suit”). … 1. This is an action for patent infringement under the patent laws of the United States arising…. This is an action for patent infringement arising under the Patent Laws of the United States, External link to document
2020-11-01 122 Opinion - Memorandum Opinion infringement of an additional patent, U.S. Patent No. 8,410,077 (the 077 patent”) (D.I. 41 Ex. C). (See generally…of U.S. Patent Nos. 9,200,088 (the “088 patent”) (D.I. 1 Ex. A); and 9,493,5 82 (the “582 patent”) (D.I…. “It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent.” fd. at 1321 (internal quotation marks omitted). The patent “specification is….” (582 patent at 6:19-34) The Court’s construction | This term appears in the 088 patent at claims External link to document
2021-06-10 149 ~Util - Terminate Civil Case AND Order States Patent Nos. 8,410,077, 9,200,088, and 9,493,582 (collectively, the "CyDex Patents")…States or with respect to any patent other than the CyDex Patents. 10. For purposes of…JUDGMENT AND DISMISSAL ORDER This action for patent infringement (the "Litigation") has been… § 355(j)(2)(A)(vii)(IV) directed to the CyDex Patents and seeking approval to market a generic melphalan…injection prior to the expiration of the CyDex Patents. CyDex and Alembic have agreed to enter External link to document
2020-01-29 39 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,410,077 B2 (First Amended Complaint…2019 10 June 2021 1:19-cv-00956 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-05-23 4 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,200,088 B2 ;9,493,582 B2. (…2019 10 June 2021 1:19-cv-00956 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Baxter
Johnson and Johnson
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.